Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Department of Research and Development, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
BMJ Glob Health. 2021 Nov;6(11). doi: 10.1136/bmjgh-2021-007433.
Early literature on the COVID-19 pandemic indicated striking ethnic inequalities in SARS-CoV-2-related outcomes. This systematic review and meta-analysis aimed to describe the presence and magnitude of associations between ethnic groups and COVID-19-related outcomes.
PubMed and Embase were searched from December 2019 through September 2020. Studies reporting extractable data (ie, crude numbers, and unadjusted or adjusted risk/ORs) by ethnic group on any of the five studied outcomes: confirmed COVID-19 infection in the general population, hospitalisation among infected patients, and disease severity, intensive care unit (ICU) admission and mortality among hospitalised patients with SARS-CoV-2 infection, were included using standardised electronic data extraction forms. We pooled data from published studies using random-effects meta-analysis.
58 studies were included from seven countries in four continents, mostly retrospective cohort studies, covering a total of almost 10 million individuals from the first wave until the summer of 2020. The risk of diagnosed SARS-CoV-2 infection was higher in most ethnic minority groups than their White counterparts in North American and Europe with the differences remaining in the US ethnic minorities after adjustment for confounders and explanatory factors. Among people with confirmed infection, African-Americans and Hispanic-Americans were also more likely than White-Americans to be hospitalised with SARS-CoV-2 infection. No increased risk of COVID-19 outcomes (ie, severe disease, ICU admission and death) was found among ethnic minority patients once hospitalised, except for a higher risk of death among ethnic minorities in Brazil.
The risk of SARS-CoV-2 diagnosis was higher in most ethnic minorities, but once hospitalised, no clear inequalities exist in COVID-19 outcomes except for the high risk of death in ethnic minorities in Brazil. The findings highlight the necessity to tackle disparities in social determinants of health, preventative opportunities and delay in healthcare use. Ethnic minorities should specifically be considered in policies mitigating negative impacts of the pandemic.
CRD42020180085.
早期关于 COVID-19 大流行的文献表明,SARS-CoV-2 相关结果在不同族裔之间存在显著的不平等。本系统综述和荟萃分析旨在描述不同族裔与 COVID-19 相关结果之间存在和程度的关联。
从 2019 年 12 月至 2020 年 9 月,我们在 PubMed 和 Embase 上进行了检索。纳入的研究报告了按族裔提取的数据(即粗数和未经调整或调整后的风险/比值比),这些数据来自五个研究结果中的任何一个:普通人群中确诊的 COVID-19 感染、感染患者的住院治疗以及疾病严重程度、住院的 SARS-CoV-2 感染患者的 ICU 入院和死亡率,使用标准化电子数据提取表纳入研究。我们使用随机效应荟萃分析汇总了已发表研究的数据。
从四大洲七个国家的 58 项研究中纳入数据,这些研究大多为回顾性队列研究,涵盖了 2020 年夏季之前第一波疫情中近 1000 万人的数据。在北美和欧洲的大多数少数民族群体中,诊断出的 SARS-CoV-2 感染风险高于其白人对应群体,而在美国少数民族群体中,在调整混杂因素和解释因素后,这种差异仍然存在。在确诊感染的人群中,非裔美国人和西班牙裔美国人因 SARS-CoV-2 感染住院的可能性也高于白人美国人。一旦住院,少数民族患者的 COVID-19 结果(即严重疾病、ICU 入院和死亡)没有发现增加的风险,但巴西的少数民族患者死亡风险较高。
在大多数少数民族群体中,SARS-CoV-2 诊断的风险较高,但一旦住院,COVID-19 结果中不存在明显的不平等,除了巴西少数民族患者的死亡风险较高之外。这些发现强调了需要解决健康的社会决定因素、预防机会和医疗保健使用延迟方面的不平等问题。在减轻大流行的负面影响的政策中,应特别考虑少数民族群体。
PROSPERO 注册号:CRD42020180085。